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RESEARCH ARTICLE
The carboxyl terminal mutational hotspot of the ciliary disease
protein RPGRORF15 (retinitis pigmentosa GTPase regulator) is
glutamylated in vivo
Kollu N. Rao, Manisha Anand and Hemant Khanna*
ABSTRACT
Mutations in RPGRORF15 (retinitis pigmentosa GTPase regulator) are
amajor cause of inherited retinal degenerative diseases. RPGRORF15
(1152 residues) is a ciliary protein involved in regulating the
composition and function of photoreceptor cilia. The mutational
hotspot in RPGRORF15 is an unusual C-terminal domain encoded by
exon ORF15, which is rich in polyglutamates and glycine residues
(Glu-Gly domain) followed by a short stretch of basic amino acid
residues (RPGRC2 domain; residues 1072-1152). However, the
properties of the ORF15-encoded domain and its involvement in
the pathogenesis of the disease are unclear. Here we show that
RPGRORF15 is glutamylated at the C-terminus, as determined by
binding to GT335, which recognizes glutamylated substrates. This
reactivity is lost in two mouse mutants of Rpgr, which do not express
RPGRORF15 due to disease-causing mutations in exon ORF15. Our
results indicate that RPGRORF15 is posttranslationally glutamylated in
the Glu-Gly domain and that the GT335 antibody predominantly
recognizes RPGRORF15 in photoreceptor cilia.
KEY WORDS: Retina, RPGR, Cilia, Glutamylation, GT335
INTRODUCTION
Retinitis pigmentosa (RP) is a group of genetically and clinically
heterogeneous disorders of the eye. RP is characterized by night
blindness due to the loss of rod photoreceptors, followed by
complete blindness due the loss of cones (Bird, 1987; Fishman,
1978). RP is inherited in autosomal dominant, autosomal recessive,
as well as X-linked manner, with over 200 causative genes
identified to date (https://sph.uth.edu/retnet/). X-linked RP is one
of the most severe forms with symptoms starting as early as in the
first decade of life, which progress into complete blindness usually
by the second decade of life (Fishman et al., 1988; Heckenlively
et al., 1988). Mutations in two genes, RPGR and RP2, account for
>80% of XLRP cases. Of these, RPGR mutations are found in
∼70% of cases. Moreover, 15-20% of simplex RP patients carry
mutations in RPGR. These data make RPGR a common cause of RP,
accounting for ∼20% of all RP cases (Churchill et al., 2013; Daiger
et al., 2007).
Photoreceptors are polarized neurons with a distinct inner
segment (IS) involved in protein synthesis and trafficking and
photosensory outer segment (which is loadedwith proteins involved
in phototransduction). The outer segment extends from the apical
region of the inner segment in the form of a narrow bridge-like
structure called microtubule-based sensory or connecting cilium
(Besharse and Bok, 2011). RPGRORF15 localizes to the connecting
cilium and is likely involved in regulating the composition of the
outer segment (Anand and Khanna, 2012; Rao et al., 2015).
RPGR is extensively alternatively spliced; however, there are two
major RPGR isoforms: constitutive RPGR (RPGRconst) and
RPGRORF15. Whereas the RPGRconst isoform encodes exons 1-19 of
the RPGR gene (amino acids 1-815), the RPGRORF15 isoform
terminates in an alternate exon ORF15, which includes exon 15 and
part of intron 15 of RPGR (amino acids 1-1152) (Anand and Khanna,
2012). Both variants share a common N-terminal domain (encoded
by exons 1-15) (Murga-Zamalloa et al., 2010). On the other hand, the
C-terminal domain of RPGRconst encoded by exons 16-19 carries an
isoprenylation motif (residues 812-815) whereas RPGRORF15
terminates in a long intron 15, which is a purine-rich region encoding
a glutamic acid-glycine (Glu-Gly)-rich acidic domain (Vervoort et al.,
2000). This domain is followed by a short stretch of basic amino acids,
termed RPGRC2 domain (residues 1071-1152). Mutation analysis
revealed that exon ORF15 is a mutational hotspot, accounting for 50-
60% of XLRP cases (Vervoort et al., 2000). The majority of human
disease-causing mutations in this exon are frameshift or nonsense
variations, which result in a premature stop codon, whereas in-frame
deletions or duplications or missense changes are tolerated.
Mouse and canine models of Rpgr have also been reported. An
Rpgrnullmouse was generated by interrupting exons 4-6 of the Rpgr
gene andwas predicted to affect the expression of all RPGR isoforms
(Hong et al., 2000). More recently, a naturally occurring Rpgrrd9
mouse model was characterized; this mouse carries a frameshift
mutation in exon ORF15 resulting in a premature stop but does not
seem to affect the expression of the RPGRconst isoform (Thompson
et al., 2012). Two canine models carrying mutations in exon ORF15
have also been reported (Zhang et al., 2002). These models represent
considerable phenotypic variability, which is consistent with
heterogenic clinical presentation of RPGRORF15 patients.
Being a mutational hotspot, it is important to evaluate the
properties of exon ORF15 of RPGR. In this study, we hypothesized
that the polyglutamate rich domain of RPGRORF15 exhibits similar
properties as the glutamate-rich regions of α-tubulin, whose C-
terminal glutamate residues are posttranslationally glutamylated
specifically in cilia.
RESULTS
Posttranslational modification of tubulin in the absence of
RPGRORF15
Microtubules are polymers of α/β tubulin heterodimers (Mitchison
and Kirschner, 1984). Tubulins undergo diverse posttranslationalReceived 5 January 2016; Accepted 18 February 2016
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modifications in an organelle or cellular substructure-specific
manner (Verhey and Gaertig, 2007). For example, ciliary
microtubules are enriched in acetylation, detyrosination and
glutamylation (Yu et al., 2015). These modifications regulate the
structure and function of the microtubule cytoskeleton (Mendes
Maia et al., 2014; O’hagan and Barr, 2012). Given that RPGR
associates with microtubule-based assemblies and that loss of
RPGR alters microtubule-based photoreceptor ciliary trafficking
(Anand and Khanna, 2012; Rao et al., 2015), we examined whether
tubulin modifications are altered in the absence of RPGR. To this
end, we used two Rpgr-mutant lines; Rpgrnull and Rpgrrd9. The
Rpgrnull mouse does not exhibit expression of RPGRconst and
RPGRORF15, whereas the Rpgrrd9 mice only express the RPGRconst
(∼90 kDa) isoform (Rao et al., 2015; Thompson et al., 2012).
Immunoblot analysis of retinal extracts from wild-type (WT),
Rpgrnull, andRpgrrd9mouse retinas using antibodies against various
post-translationally modified tubulin revealed no changes in the
levels of acetylated α-tubulin, detyrosinated tubulin or glutamylated
tubulin (B3 and GT335) (Fig. 1A-D).
RPGRORF15 is a target of GT335
During our analysis, we found that the GT335 antibody, in addition
to detecting the glutamylated tubulin-specific band at ∼50 kDa,
recognized a higher molecular weight band (∼200 kDa) in WT
mouse retinal extracts (Fig. 1D). This band was of the same
molecular weight as the RPGRORF15-immunoreactive band, as
determined by western blotting using anti-RPGR antibody
(Fig. 1E). We did not detect a similar immunoreactive band
(∼200 kDa) using B3 antibody (not shown). Previous studies
showed that in addition to tubulins, GT335 recognizes other targets
of glutamylation, such as nucleosome assembly proteins, NAP1 and
NAP2 (Regnard et al., 2000). However, B3 antibody specifically
detects polyglutamylated α-tubulin (Van Dijk et al., 2007).
The GT335 antibody was raised against an octapeptide
EGEGE*EEG, which is modified by the addition of two glutamyl
subunits on the fifthE (*). TheC-terminusofRPGRORF15, on theother
hand, predominantly carries GEEEEG and GEEEG repeats. These
repeats could potentially be substrates for glutamylation. We thus
asked whether the GT335 antibody cross-reacts with an unknown
protein of the same molecular weight as RPGRORF15 or specifically
recognizes the C-terminal domain of RPGRORF15. We examined the
expression of this band in the Rpgrnull and the Rpgrrd9 retinas. Our
hypothesis was that if this band were a cross-reacting species, then we
would observe it even in the absence of RPGRORF15; however, if this
reactivitywere specific, thenwewouldnot observe this highmolecular
weight band in Rpgrrd9 (frameshift mutation in exon ORF15) and
Rpgrnull retinal extracts. Immunoblot analysis revealed that the
GT335-immunoreactive band was undetectable in the Rpgrnull and
Rpgrrd9 retinal extracts (Fig. 1D). The GT335 antibody is a well-
characterized antibody, which specifically recognizes the first branch
point glutamate added to the target residue (Van Dijk et al., 2007;
Wolff et al., 1992). Thus, this reactivity does not distinguish between
mono- and polyglutamylated RPGRORF15. To clarify this, we
performed immunoblot analysis using polyE antibody, which
recognizes long polyglutamylated side chains (Magiera and Janke,
2013). As shown in Fig. 1F, polyE antibody did not detect the high
molecular band; however, tubulin-specific bands at ∼50 kDa were
detected. These results indicate that RPGRORF15 is most likely
monoglutamylated.
RPGRORF15 associates with GT335 in the retina
To further validate the binding of GT335 to RPGRORF15, we
performed immunoprecipitation from mouse retina using anti-
RPGRORF15 antibody followed by immunoblotting using GT335
antibody or anti-RPGRORF15 antibody. RPGR immunoprecipitation
pulled down both RPGRORF15 and RPGRconst isoforms from
the wild type retinal extracts but not from Rpgrnull mice; however,
the GT335-immunoreactive band coincided with anti-RPGRORF15-
reactive band (Fig. 2A, right panel). Furthermore,
immunofluorescence analysis of wild-type mouse retina using
anti-RPGR and GT335 antibodies showed that they co-localize at
the connecting cilium (CC) (Fig. 2B).
Immunofluorescence analysis of GT335 in Rpgrnull mouse
retina
GT335 recognizes polyglutamylated tubulin in microtubules, which
are abundant in the cilia. To test whether the ciliary staining of
GT335 is altered in the absence of RPGR, we performed
immunofluorescence analysis of wild-type and Rpgrnull mouse
retina. Our analysis revealed reduced staining of GT335 in the
Rpgrnull photoreceptor connecting cilium. As shown in Fig. 2C,
co-localization of GT335 with anti-CEP290 (a connecting cilium
marker; arrows pointing to yellow spots) (Murga-Zamalloa et al.,
2011) is observed in wild type retinal sections but not in the Rpgrnull
retinas, which predominantly exhibits green signal corresponding to
anti-CEP290 antibody, in the connecting cilium. These data indicate
that in photoreceptor cilia, the ciliary staining of GT335 is largely
mediated by binding to glutamylated RPGR. Such staining is
diminished in the Rpgrnull mouse retina.
Human RPGRORF15 is immunoreactive to GT335
The studies described above were carried out using mouse retinal
extracts. We also wanted to validate these findings in human RPGR
protein. Using immunoreactivity to GT335 as a tractable assay
Fig. 1. GT335 detects RPGRORF15. (A-C) Immunoblot (IB) analysis of retinal extracts from wild type (WT), Rpgrnull and Rpgrrd9 mice was performed using
antibodies against indicated forms of tubulin. An equal amount of protein extract (30 µg) was loaded in each lane. (D-F) Retinal extracts from indicated mouse
strains were analyzed by SDS-PAGE and immunoblotting using anti-GT335 (D), anti-RPGR (E) or anti-polyE (F) antibodies. Arrow in D indicates the tubulin-
reactive band whereas arrowhead points to the RPGRORF15 band. Three independent replicates were performed for these experiments.
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system, we asked whether GT335 also recognizes both major
variants of human RPGR: RPGRconst and RPGRORF15 protein.
We transiently transfected hTERT-RPE1 cells with mammalian
expression constructs encoding Xpress (Xp)-tagged human
RPGRconst and RPGRORF15 (Fig. 3A), followed by SDS-PAGE
and immunoblotting of protein extracts using anti-Xp or GT335
antibodies. As shown in Fig. 3B, GT335-immunoreactivity was
detected only in cells expressing Xp-RPGRORF15. Immunoblotting
using anti-Xpress antibody validated the expression of the
recombinant human RPGR proteins. These results suggest that the
C-terminal glutamic acid rich domain of RPGRORF15 is a likely
target for glutamylation.
Disease-causing mutations in RPGRORF15 alter its binding to
GT335
We hypothesized that disease-associated mutations in exon ORF15,
which alter the polyglutamate repeats affect its glutamylation and
thus, reactivity to GT335. To test this, we transiently transfected
hTER-RPE1 cells with constructs encoding Xp-tagged RPGRORF15
and truncated versions of RPGRORF15: RPGRORF15-1071X and
RPGRORF15-853X (Fig. 4A). Immunoblot analysis of protein
extracts using GT335 antibody revealed that whereas full length
RPGRORF15 was recognized by GT335, RPGRORF15-Glu1071X
exhibited ∼50% reactivity and RPGRORF15-Glu853X exhibited
only ∼0.1% immunoreactivity to GT335 (Fig. 4B).
DISCUSSION
Our studies reveal two key findings: (i) a novel molecule that is
recognized by GT335. In fact, RPGRORF15 is likely the fifth
molecule that is recognized by GT335; the first four being
α-tubulin, β-tubulin, NAP1 and NAP2 (Regnard et al., 2000); (ii)
sequence alterations in the Glu-Gly domain of RPGRORF15 alter its
glutamylation. However, the function of glutamylated RPGRORF15
is not known. We propose that glutamylated RPGRORF15 regulates
the integrity of the multiprotein complexes at the cilium and
modulates their entry or retention inside the cilium. However,
human disease mutations in the polyglutamate-rich region appear to
alter the length of this region (and the amount of polyglutamates)
and are associated with relatively mild retinal dysfunction in
patients. Thus, alterations in the glutamylation of RPGRORF15 may
compromise but not eliminate its function. Evaluation of complete
Fig. 2. GT335 association and reactivity in Rpgrnull retina. (A) Retinal
extracts from wild type (WT) and Rpgrnull mice were subjected to
immunoprecipitation (IP) using anti-RPGR antibody followed by SDS-PAGE
and immunoblotting using anti-RPGR (left) or GT335 (right) antibody. Input
lane shows 10% of the protein extract used in IP. (B,C) Cryosections of wild
type (WT; B; upper panel, C) and 2-month-old Rpgrnull (C) mouse retinas were
stained with anti-RPGR (B; green) or anti-CEP290 (panel C; green), and anti-
GT335 (red; B,C) antibodies. Arrows in merge point to co-localization of RPGR
or CEP290 with GT335-specific signal. Scale bar: 2 µm in B; 5 µm in C. Nuclei
were stained with Hoechst (blue). CC, connecting cilium; IS, photoreceptor
inner segment; ONL, photoreceptor outer nuclear layer. These experiments
were repeated three times with independent mouse retinal samples.
Fig. 3. Human RPGRORF15 reacts with GT335. (A) This panel depicts a
schematic representation of the human RPGRconst and RPGRORF15 isoforms.
Numbers denote the positons of amino acid residues. RLD, RCC1-like domain;
Glu-Gly, glutamic acid and glycine rich domain. (B) hTERT-RPE1 cells were
transiently transfected with constructs encoding Xp-RPGRconst or Xp-
RPGRORF15. An equal amount of cell extract was analyzed by SDS-PAGE and
immunoblotting using anti-Xpress or GT335 antibody. All experiments were
repeated three independent times.
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loss of the ORF15 domain on ciliary function will provide insights
into the precise role of glutamylation of RPGRORF15.
What is the mechanism of glutamylation of RPGRORF15?
Glutamylation is an evolutionarily conserved and is a widely
distributed modification involved in diverse functions (Janke et al.,
2008; Van Dijk et al., 2008). Moreover, tubulin glutamylation occurs
at the C-terminal glutamate-rich region (Edde et al., 1990) and is
carried out by tubulin tyrosine ligase-like (TTLL) family of proteins
(Raunser and Gatsogiannis, 2015). Recently, a member of the TTLL
family, TTLL5, was reported to be involved in human retinal
degeneration (Sergouniotis et al., 2014). We propose that TTLL5 or
another TTLL family member is a candidate glutamylase for
RPGRORF15. A Ttll5ko mouse model was reported to have sperm
defects; however, retinal defects were not detected in this model (Lee
et al., 2013). It is possible that the defects could occur at ages older
than those tested in that study. Further studies to test these scenarios
have the potential to reveal critical insights into the pathogenesis of
retinal degeneration due to defective posttranslational modifications
of ciliary proteins. Our results showing that RPGRORF15-Glu1071X
exhibited ∼50% reactivity and RPGRORF15-Glu853X exhibited only
∼0.1% immunoreactivity to GT335 suggest the involvement of C2
domain in efficient glutamylation of RPGRORF15; however, both the
Glu-Gly domain and the C2 domainmay be critical for glutamylation
of RPGRORF15. We propose that the C2 domain may act as a binding
site for the enzymes and that both theGlu-Gly domain andC2domain
work in concert for efficient binding and glutamylation reactions.
Although our data indicate that RPGRORF15 is likely
monoglutamylated, we cannot rule out the possibility that
RPGRORF15 is polyglutamylated. This is because the C-terminus of
RPGRORF15 predominantly carries GEEEEG and GEEEG repeats,
which could be glutamylated in tandem. However, identification of
the glutamylase will provide further insights into the glutamylation
status of RPGRORF15. For example, TTLL4, TTLL5, and TTLL7 are
side-chain initiating polyglutamylases, TTLL6, TTLL11 and
TTLL13 preferentially elongate the side chains. Nonetheless,
glutamylation of RPGRORF15 may alter the function of RPGR by
modulating its ability to interact with other proteins at the cilium due
to changes in the net charge of theGlu-Gly domain. Further studies are
underway to assess the effect of glutamylation of RPGRORF15 on its
ability to maintain the integrity of its interactome and/or interact with
additional proteins. Overall, these studies will provide new insights
into the mode of regulation of ciliary protein trafficking and
pathogenesis of associated ciliopathies.
MATERIALS AND METHODS
Animals
All studies involving animals were approved by the Institutional Animal
Care and Use Committee of UMASS Medical School. Wild type C57BL6/J
and Rpgrrd9 mice were procured from Jackson Labs; Rpgrnull mice were
obtained from Dr Tiansen Li (National Eye Institute). Only hemizygous
male mice were used in this study as Rpgr is an X-linked gene.
Antibodies
The GT335 (1:500 dilution) and polyE (1:200 dilution) antibodies were
obtained from AdipoGen (San Diego, CA); anti-anti-acetylated α-tubulin
(1:1000 dilution) and anti-polyglutamylated tubulin B3 (1:500 dilution)
were obtained from Sigma-Aldrich; anti-detyrosinated antibody
was obtained from Abcam; anti-Xpress antibody (1:200 dilution) was
procured from Invitrogen. Anti-RPGR antibody (1:500 dilution) was raised
against an N-terminal epitope, which is common to both RPGRconst and
RPGRORF15 isoforms. Detailed characterization of this antibody was
previously reported (Ghosh et al., 2010; Rao et al., 2015).
Plasmids, cell culture, transient transfection and IP
The human cDNA encoding full-length human RPGRconst and RPGRORF15
were cloned into pcDNA4 (Invitrogen), which expressed N-terminally
Fig. 4. Human disease mutations in RPGRORF15 alter
binding to GT335. (A) Schematic representation of the location
of the human exon ORF15 mutations. RLD, RCC1-like domain;
Glu-Gly, glutamic acid and glycine rich domain; C2, RPGRC2
domain. (B) hTERT-RPE1 cells were transiently transfected
with constructs encoding Xpress-tagged full-length RPGRORF15
or two disease-causing mutants; RPGRORF15-1071X or
RPGRORF15-853X. Equal amount of protein extracts from these
cells were analyzed by SDS-PAGE and immunoblotting using
anti-Xpress (upper panel) or anti-GT335 (lower panel) antibody.
Asterisk indicates degraded protein product. Densitometric
analysis was performed to quantify the immunoblot signal. The
data are represented as ratio relative to the intensity of GT335-
immunoreactivity with full-length RPGRORF15, set as 1. Error
bars represent standard deviation. *P<0.001; **P<0.0001. Data
are representative of three independent experiments.
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X-press-tagged recombinant proteins, and sequence verified. hTERT-RPE1
cells (ATCC)weremaintained in DMEM/F12 (Invitrogen) supplementedwith
10% fetal bovine serum and penicillin/streptomycin and tested for
contamination. Transient transfections were performed using Lipofectamine
2000 (Invitrogen). Cells were lysed 48 h post-transfection in lysis buffer
containing 25 mMTris, 150 mMNaCl, 1 mMEDTA, 1%NP-40, 5%glycerol
(pH 7.4) with Complete protease inhibitors (Roche) and lysates were spun at
18,000×g for 15 min at 4°C. Equal amount of protein was analyzed by SDS-
PAGE and immunoblotting, as described (Khanna et al., 2005).
Immunoprecipitation of mouse retinal extracts was performed, as described
(Khanna et al., 2005). All experiments were repeated three independent times.
Immunofluorescence
Staining of mouse retina was performed as described (Li et al., 2013).
Cryosections of mouse retinas fixed in 4% paraformaldehyde were
permeabilized and blocked using 5% normal goat serum followed by
incubation with primary antibody overnight at 4°C. Slides were then washed
three times with phosphate buffered saline and further incubated with
secondary antibody for 1 h at room temperature. Hoechst 33342 (Life
Technologies) was added (1 µg/ml) to label the nuclei and the sections were
then mounted (Fluoromount; Electron Microscopy Services, Hatfield, PA)
under glass coverslips and visualized using Leica TCSSp5 II lasermicroscope
(Leica Microsystems).
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